C Eduardo Corrales1, Neil Bhattacharyya1. 1. Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, and Department of Otology and Laryngology, Harvard Medical School, Boston, Massachusetts, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: To determine if dizziness is an independent risk factor for mortality among adults in the United States. STUDY DESIGN: Cross-sectional analysis using the National Health Interview Survey (NHIS). METHODS: Adult respondents in the 2008 NHIS were evaluated. Demographic information (gender, race, ethnicity, education level), prevalence of dizziness, mortality rates, and leading causes of death (cardiovascular disease, cancer, diabetes, cerebrovascular disease) were collected and analyzed. The association between dizziness and subsequent mortality was determined adjusting for demographic and other disease factors. RESULTS: Among 213.6 ± 3.5 million adult Americans, 23.8 ± 0.7 million reported dizziness in the past 12 months (11.1% ± 0.3%; mean age, 45.9 ± 0.2 years; 51.7% ± 0.5% female). The mortality rate among the group without dizziness in the preceding 12 months was 2.6% ± 0.1%, compared to the dizzy group at 9.0% ± 0.7%. After adjusting for gender and age, there was a statistically significant association between dizziness and mortality (odds ratio [OR]: 2.2, 95% confidence interval [CI]: 1.8-2.8). After adjusting for all covariates including age, ethnicity, race, gender, diabetes, cardiovascular, cerebrovascular disease, cancer, and grade level, dizziness remained an independent predictor of increased mortality (adjusted OR: 1.7, 95% CI: 1.36-2.18). CONCLUSIONS: Approximately 11% of adult Americans reported dizziness or balance problems in the preceding 12 months. Adults with dizziness have a greater mortality rate than nondizzy adults. Even after adjusting for covariates, there was a significant association between dizziness and mortality. Screening for dizziness as a risk factor for mortality may be warranted. LEVEL OF EVIDENCE: 2b Laryngoscope, 126:2134-2136, 2016.
OBJECTIVES/HYPOTHESIS: To determine if dizziness is an independent risk factor for mortality among adults in the United States. STUDY DESIGN: Cross-sectional analysis using the National Health Interview Survey (NHIS). METHODS: Adult respondents in the 2008 NHIS were evaluated. Demographic information (gender, race, ethnicity, education level), prevalence of dizziness, mortality rates, and leading causes of death (cardiovascular disease, cancer, diabetes, cerebrovascular disease) were collected and analyzed. The association between dizziness and subsequent mortality was determined adjusting for demographic and other disease factors. RESULTS: Among 213.6 ± 3.5 million adult Americans, 23.8 ± 0.7 million reported dizziness in the past 12 months (11.1% ± 0.3%; mean age, 45.9 ± 0.2 years; 51.7% ± 0.5% female). The mortality rate among the group without dizziness in the preceding 12 months was 2.6% ± 0.1%, compared to the dizzy group at 9.0% ± 0.7%. After adjusting for gender and age, there was a statistically significant association between dizziness and mortality (odds ratio [OR]: 2.2, 95% confidence interval [CI]: 1.8-2.8). After adjusting for all covariates including age, ethnicity, race, gender, diabetes, cardiovascular, cerebrovascular disease, cancer, and grade level, dizziness remained an independent predictor of increased mortality (adjusted OR: 1.7, 95% CI: 1.36-2.18). CONCLUSIONS: Approximately 11% of adult Americans reported dizziness or balance problems in the preceding 12 months. Adults with dizziness have a greater mortality rate than nondizzy adults. Even after adjusting for covariates, there was a significant association between dizziness and mortality. Screening for dizziness as a risk factor for mortality may be warranted. LEVEL OF EVIDENCE: 2b Laryngoscope, 126:2134-2136, 2016.
Authors: Vincent A van Vugt; Gülsün Bas; Johannes C van der Wouden; Jacquelien Dros; Henk C P M van Weert; Lucy Yardley; Jos W R Twisk; Henriëtte E van der Horst; Otto R Maarsingh Journal: Ann Fam Med Date: 2020-03 Impact factor: 5.166
Authors: Michael Strupp; Julia Dlugaiczyk; Birgit Bettina Ertl-Wagner; Dan Rujescu; Martin Westhofen; Marianne Dieterich Journal: Dtsch Arztebl Int Date: 2020-04-24 Impact factor: 5.594
Authors: Katharina Feil; Regina Feuerecker; Nicolina Goldschagg; Ralf Strobl; Thomas Brandt; Albrecht von Müller; Eva Grill; Michael Strupp Journal: Front Neurol Date: 2018-02-27 Impact factor: 4.003
Authors: Jan Erik Berge; Frederik Kragerud Goplen; Hans Jørgen Aarstad; Tobias Andre Storhaug; Stein Helge Glad Nordahl Journal: Front Neurol Date: 2022-08-05 Impact factor: 4.086
Authors: J Münst; A Pudszuhn; M V Bernstorff; T Obermueller; H Erdur; H J Audebert; M Rose; A Reisshauer; I Hoffmann; U Schönfeld; V M Hofmann Journal: HNO Date: 2021-05-04 Impact factor: 1.284